Showing results (5251-5260 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|September 24, 2020
Clinical Benefit of Tyrosine Kinase Inhibitors in Advanced Lung Cancer with EGFR-G719A and Other Uncommon EGFR MutationsKartik Sehgal, Deepa Rangachari, Paul A VanderLaan, et al.
The Oncologist|September 24, 2020
D-Dimer Enhances Risk-Targeted Thromboprophylaxis in Ambulatory Patients with CancerVaibhav Kumar, Joseph R Shaw, Nigel S Key, et al.
The Oncologist|September 12, 2020
A Timely Oral Option: Single-Agent Vinorelbine in Desmoid TumorsSpyridon Gennatas, Florence Chamberlain, Alannah Smrke, et al.
The Oncologist|January 17, 2020
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup AnalysisGerardo Rosati, Fabio Galli, Maurizio Cantore, et al.
The Oncologist|January 17, 2020
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database AnalysisMadhusmita Behera, Conor E Steuer, Yuan Liu, et al.
The Oncologist|January 11, 2020
Inverse Association of Age with Risk of Lymph Node Metastasis in Superficial Colorectal Cancer: A Large Population-Based StudyQing-Wei Zhang, Long-Ci Sun, Chao-Tao Tang, et al.
The Oncologist|March 11, 2020
Phase II Multicenter, Open-Label Study of Oral ENMD-2076 for the Treatment of Patients with Advanced Fibrolamellar CarcinomaGhassan K Abou-Alfa, Robert Mayer, Alan P Venook, et al.
The Oncologist|March 14, 2020
"My Research Is Their Business, but I'm Not Their Business": Patient and Clinician Perspectives on Commercialization of Precision Oncology DataKayte Spector-Bagdady, Chris D Krenz, Collin Brummel, et al.
The Oncologist|March 17, 2020
Hormone Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted AgentsAmi N Shah, Otto Metzger, Cynthia Huang Bartlett, et al.
The Oncologist|October 24, 2020
Phase II Trial of Neoadjuvant Carboplatin and Nab-Paclitaxel in Patients with Triple-Negative Breast CancerYuan Yuan, Jin Sun Lee, Susan E Yost, et al.
Pageof 571